 Oncogene Protein v-akt
"Oncogene Protein v-akt" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A viral oncoprotein originally isolated from a murine T CELL LYMPHOMA infected with the acutely transforming retrovirus AKT8. v-akt protein is the viral homologue of PROTO-ONCOGENE PROTEINS C-AKT.
| Descriptor ID |
D051058
|
| MeSH Number(s) |
D08.811.913.696.620.682.700.586 D12.776.624.664.520.750.788
|
| Concept/Terms |
Oncogene Protein v-akt- Oncogene Protein v-akt
- Oncogene Protein v akt
- v-akt, Oncogene Protein
- v-akt Protein
- v-akt Kinase Transforming Protein
- v akt Kinase Transforming Protein
- akt-Oncogene Protein
- akt Oncogene Protein
- Oncogene Protein akt
- akt, Oncogene Protein
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Protein v-akt".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Protein v-akt".
This graph shows the total number of publications written about "Oncogene Protein v-akt" by people in UAMS Profiles by year, and whether "Oncogene Protein v-akt" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 0 | 1 | 1 | | 2014 | 1 | 1 | 2 | | 2012 | 0 | 1 | 1 | | 2011 | 0 | 1 | 1 | | 2010 | 0 | 1 | 1 | | 2009 | 0 | 1 | 1 | | 2008 | 1 | 0 | 1 | | 2006 | 2 | 1 | 3 | | 2005 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Oncogene Protein v-akt" by people in Profiles over the past ten years.
-
Subathra M, Korrapati M, Howell LA, Arthur JM, Shayman JA, Schnellmann RG, Siskind LJ. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Am J Physiol Renal Physiol. 2015 Aug 01; 309(3):F204-15.
-
Beck JT, Ismail A, Tolomeo C. Targeting the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway: an emerging treatment strategy for squamous cell lung carcinoma. Cancer Treat Rev. 2014 Sep; 40(8):980-9.
-
Xie L, Chen J, McMickle A, Awar N, Nady S, Sredni B, Drew PD, Yu S. The immunomodulator AS101 suppresses production of inflammatory cytokines and ameliorates the pathogenesis of experimental autoimmune encephalomyelitis. J Neuroimmunol. 2014 Aug 15; 273(1-2):31-41.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|